본문 바로가기
KERD
논문KCI 등재

Assessment of Human Immunodeficiency Virus Care Continuum in Korea using the National Health Insurance System Data

2

조회

0

다운로드

5

인용

0

참고문헌

키워드

주제분류내과학

초록

Background: Antiretroviral therapy (ART) has been shown to significantly reduce the likelihood of transmission to other people as well as promoting the health of people living with Human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) (PLH). The purpose of this study was to assess the HIV care continuum of PLH in Korea using the national health insurance system (NHIS) database. Materials and Methods: From 2006 to 2015, ART prescription/laboratory test claim data and enlisted accompanying comorbidities were extracted from the NHIS database. Utilizing these data, proportion of PLH on ART among those who registered to Korea Disease Control and Prevention Agency (KDCA), HIV viral load testing, prescription trends of ART, medication possession ratio (MPR) of ART, and accompanying comorbidities were reviewed. Factors related with MPR <90% was also investigated among demographic factors, ART prescription, and accompanying comorbidities. Results: During the observation period, the number of people receiving ART prescription increased from 2,076 in 2006 to 9,201 in 2015. Considering the number of PLHs reported by the KDCA, the proportion of PLHs who received ART prescription increased from 55.4% to 87.6% during the study period. The median value of ART MPR increased from 76.4% to 94.2% and the proportion of patients with MPR >90% increased from 54.3% to 78.2%. The most commonly accompanying comorbidities were dyslipidemia (55.7%), osteoporosis (16.3%), hypertension (15.7%) and diabetes (13.7%), respectively. The proportion of PLH with two or more comorbid conditions increased from 22.0% to 31.6%. Regarding the factors associated with suboptimal compliance, age less than 50 years old, under support of National Medical Aid, alcoholic liver disease, mental and behavioral disorders due to use of alcohol, and ART regimen of protease inhibitor and non-single table regimen integrase strand transfer inhibitor were related with MPR <90%. Conclusion: The proportion of PLHs who received ART prescription and median MPR of ART increased during the study period. However, proportion of patients with MPR >90% was 78.2% in 2015 and there are still much room for improvement in the aspect of compliance.

Abstract

Background: Antiretroviral therapy (ART) has been shown to significantly reduce the likelihood of transmission to other people as well as promoting the health of people living with Human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) (PLH). The purpose of this study was to assess the HIV care continuum of PLH in Korea using the national health insurance system (NHIS) database. Materials and Methods: From 2006 to 2015, ART prescription/laboratory test claim data and enlisted accompanying comorbidities were extracted from the NHIS database. Utilizing these data, proportion of PLH on ART among those who registered to Korea Disease Control and Prevention Agency (KDCA), HIV viral load testing, prescription trends of ART, medication possession ratio (MPR) of ART, and accompanying comorbidities were reviewed. Factors related with MPR <90% was also investigated among demographic factors, ART prescription, and accompanying comorbidities. Results: During the observation period, the number of people receiving ART prescription increased from 2,076 in 2006 to 9,201 in 2015. Considering the number of PLHs reported by the KDCA, the proportion of PLHs who received ART prescription increased from 55.4% to 87.6% during the study period. The median value of ART MPR increased from 76.4% to 94.2% and the proportion of patients with MPR >90% increased from 54.3% to 78.2%. The most commonly accompanying comorbidities were dyslipidemia (55.7%), osteoporosis (16.3%), hypertension (15.7%) and diabetes (13.7%), respectively. The proportion of PLH with two or more comorbid conditions increased from 22.0% to 31.6%. Regarding the factors associated with suboptimal compliance, age less than 50 years old, under support of National Medical Aid, alcoholic liver disease, mental and behavioral disorders due to use of alcohol, and ART regimen of protease inhibitor and non-single table regimen integrase strand transfer inhibitor were related with MPR <90%. Conclusion: The proportion of PLHs who received ART prescription and median MPR of ART increased during the study period. However, proportion of patients with MPR >90% was 78.2% in 2015 and there are still much room for improvement in the aspect of compliance.

참고문헌 (32)

  1. Rodger AJ, "Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study", Lancet, 393, pp.2428~2438 (2019)
  2. "90-90-90: an ambitious treatment target to help end the AIDS epidemic"[URL]
  3. "HIV Surveillance report. Supplemental report Volume 25, Number 2: Monitoring selected HIV prevention and care objectives using surveillance data, United States and 6 dependent areas"[URL]
  4. Brown AE, "HIV in Europe and Central Asia: progress in 2018 towards meeting the UNAIDS 90-90-90 targets", Euro Surveill, 23, pp.1800622~ (2018)
  5. Eun Young Lee, "Estimation of the Number of HIV Infections and Time to Diagnosis in the Korea", Journal of Korean Medical Science, 35(6), pp.1~10 (2020), 대한의학회[DOI]
  6. Yoo M, "Characteristics of adolescents and young adults with HIV in the Republic of Korea from 2010 through 2015", Sci Rep, 10, pp.9384~ (2020)
  7. Kim J, "Adherence to antiretroviral therapy and factors affecting low medication adherence among incident HIV-infected individuals during 2009-2016: A nationwide study", Sci Rep, 8, pp.3133~ (2018)
  8. 대한에이즈학회, "국내 HIV 감염인의 HIV", AIDS 진단 및 치료에 관한 임상진료지침 권고안, 2011, pp.43(2), 89~128[DOI]
  9. 위성헌, "The 2013 Clinical Guidelines for the Diagnosis and Treatment of HIV", AIDS in HIV-Infected Koreans, 2013, pp.45(4), 455~461[DOI]
  10. "Selected national HIV prevention and care outcomes"[URL]
  11. Rebeiro PF, "Laboratory measures as proxies for primary care encounters: implications for quantifying clinical retention among HIV-infected adults in North America", Am J Epidemiol, 182, pp.952~960 (2015)
  12. Mugavero MJ, "Measuring retention in HIV care: the elusive gold standard", J Acquir Immune Defic Syndr, 61, pp.574~580 (2012)
  13. Poteat T, "Characterizing the human immunodeficiency virus care continuum among transgender women and cisgender women and men in clinical care: a retrospective time-series analysis", Clin Infect Dis, 70, pp.1131~1138 (2020)
  14. "The yearbook of surveillance for HIV/AIDS in the South Korea"[URL]
  15. "Thematic report: continuum of HIV care" (2017)[URL]
  16. 최윤수, "Epidemiological characteristics of HIV infected Korean: Korea HIV", AIDS Cohort Study, 2019, pp.41, 1~9[DOI]
  17. Kweon S, "Data resource profile: the Korea national health and nutrition examination Survey (KNHANES)", Int J Epidemiol, 43, pp.69~77 (2014)
  18. "Diabetes fact sheet in Korea" (2018)[URL]
  19. 김희성, "Prevalence and Risk Factors of Low Bone Mineral Density in Korean HIV-Infected Patients: Impact of Abacavir and Zidovudine", Journal of Korean Medical Science, 28(6), pp.827~832 (2013), 대한의학회
  20. "Osteoporosis and osteoporotic fracture fact sheet" (2017)[URL]
  21. 김용찬, "Human Immunodeficiency Virus (HIV) and Hepatitis Virus Coinfection among HIV-Infected Korean Patients: The Korea HIV", AIDS Cohort Study, 2017, pp.49(4), 268~274[DOI]
  22. Goldman JD, "Simple adherence assessments to predict virologic failure among HIV-infected adults with discordant immunologic and clinical responses to antiretroviral therapy", AIDS Res Hum Retroviruses, 24, pp.1031~1035 (2008)
  23. "Meeting report on assessment of World Health Organization HIV drug resistance early warning indicators: report of the Early Advisory Indicator Panel meeting, 11-12August 2011, Geneva, Switzerland"[URL]
  24. Desta AA, "Level of adherence and associated factors among HIVinfected patients on antiretroviral therapy in Northern Ethiopia: retrospective analysis", Patient Prefer Adherence, 14, pp.1585~1594 (2020)
  25. MacDonell K, "Barriers to medication adherence in behaviorally and perinatally infected youth living with HIV", AIDS Behav, 17, pp.86~93 (2013)
  26. Rudy BJ, "Prevalence and interactions of patient-related risks for nonadherence to antiretroviral therapy among perinatally infected youth in the United States", AIDS Patient Care STDS, 24, pp.97~104 (2010)
  27. Dejesus E, "Simplification of antiretroviral therapy to a single-tablet regimen consisting of efavirenz, emtricitabine, and tenofovir disoproxil fumarate versus unmodified antiretroviral therapy in virologically suppressed HIV-1-infected patients", J Acquir Immune Defic Syndr, 51, pp.163~174 (2009)
  28. Hodder SL, "Patient-reported outcomes in virologically suppressed, HIV-1-Infected subjects after switching to a simplified, single-tablet regimen of efavirenz, emtricitabine, and tenofovir DF", AIDS Patient Care STDS, 24, pp.87~96 (2010)
  29. 김민정, "Causes of HIV Drug Non-Adherence in Korea: Korea HIV", AIDS Cohort Study, 2006-2015, 2017, pp.49(3), 213~218[DOI]
  30. Hamers RL, "Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART)failure in 6 sub-Saharan African countries: implications for second-line ART strategies", Clin Infect Dis, 54, pp.1660~1669 (2012)
  31. Galvan FH, "The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV cost and services utilization study", J Stud Alcohol, 63, pp.179~186 (2002)
  32. Paolillo EW, "At-Risk Alcohol Use is Associated with Antiretroviral Treatment Nonadherence Among Adults Living with HIV", AIDS, 2017, pp.41, 1518~1525

관련 논문AI추천

Rate of and Risk Factors for Loss to Follow Up in HIV-Infected Patients in Korea: The Korea HIV/AIDS Cohort Study성혜, 김상일, 김신우, 김윤정, 박대원, 송준영, Choi Bo Youl, Choi Jun-Yong, Choi Yunsu, Kim Jung Ho, Kim Minjeong, Park Boyoung대한감염학회 · Infection and Chemotherapy2023 · 제55권 제1호Survival Trend of HIV/AIDS Patients Starting Antiretroviral Therapy in South Korea between 2001 and 2015기미경, 김민자, 김상일, 김수민, 김신우, 김용찬, 김효열, 박대원, 송준영, 안진영, 유명수, 최보율, 최윤수, 최준용, 최희정, 한명국연세대학교의과대학 · Yonsei Medical Journal2020 · 제61권 제8호Causes of HIV Drug Non-Adherence in Korea: Korea HIV/AIDS Cohort Study, 2006-2015강춘, 기미경, 김민자, 김민정, 김상일, 김신우, 김준명, 김효열, 송준영, 우준희, 이상아, 장현하, 최보율, 최윤수, 최주연, 최준용, Korea HIV/AIDS Cohort Study대한감염학회 · Infection and Chemotherapy2017 · 제49권 제3호Trend of CD4+ Cell Counts at Diagnosis and Initiation of Highly Active Antiretroviral Therapy (HAART): Korea HIV/AIDS Cohort Study, 1992-2015강춘, 기미경, 김민정, 김상일, 김수민, 김신우, 김우주, 김윤정, 김준명, 박대원, 이진수, 장현하, 최보율, 최영화, 최주연, 최준용, Korea HIV/AIDS Cohort Study대한감염학회 · Infection and Chemotherapy2017 · 제49권 제2호Epidemiological Characteristics of HIV-Infected Individuals by the Registration for Special Exempted Calculation: A Nationwide Cohort StudyAhn Kyoung Hwan, Choi Bo Youl, Choi Jungsoon, Choi Yunsu, Jun Yoon Hee, Kim Jung Ho, Kim Shin-Woo, Kim Soo Min, Kim Youn Jeong, Park Bo Young대한감염학회 · Infection and Chemotherapy2024 · 제56권 제4호Comparison of Characteristics and Survival between Prospective and Retrospective Korea Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome Cohort Studies기미경, 김상일, 김신우, 김준형, 송준영, 최보율, 최윤수, 최준용대한감염학회 · Infection and Chemotherapy2019 · 제51권 제4호

이 간행물의 다른 논문 (24건)